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Abstract
The purpose of these experiments was to examine the effects of dietary antioxidant supplementation with 
vitamin E (VE) and a-lipoic acid (a-LA) on biochemical and physiological responses to in vivo myocardial 
ischemia-reperfusion (I-R) in aged rats. Male Fischer-334 rats (18 mo old) were assigned to either1) a 
control diet (CON) or 2)aVEanda-LA supplemented diet (ANTIOX). After a 14-wk feeding period, 
animals in each group underwent an in vivo I-R protocol (25 min of myocardial ischemia and 15 min of 
reperfusion). During reperfusion, peak arterial pressure was significantly higher (P,0.05) in ANTIOX 
animals compared with CON diet animals. I-R resulted in a significant increase ( P,0.05) in myocardial 
lipid peroxidation in CON diet animals but not in ANTIOX animals. Compared with ANTIOX animals, 
heart homogenates from CON animals experienced significantly less (P,0.05) oxidative damage when 
exposed to five different in vitro radical producing systems. These data indicate that dietary 
supplementation with VE and a-LA protects the aged rat heart from I-R-induced lipid peroxidation by 
scavenging numerous reactive oxygen species. Importantly, this protection is associated with improved 
cardiac performance during reperfusion.
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2000.—The purpose of these experiments was to examine the 
effects of dietary antioxidant supplementation with vitamin 
E (VE) and a-lipoic acid (a-LA) on biochemical and physio- 
logical responses to in vivo myocardial ischemia-reperfusion 
(I-R) in aged rats. Male Fischer-334 rats (18 mo old) were 
assigned to either 1) a control diet (CON) or 2) a VE and a-LA 
supplemented diet (ANTIOX). After a 14-wk feeding period, 
animals in each group underwent an in vivo I-R protocol (25 
min of myocardial ischemia and 15 min of reperfusion). 
During reperfusion, peak arterial pressure was significantly 
higher (P < 0.05) in ANTIOX animals compared with CON 
diet animals. I-R resulted in a significant increase (P < 0.05) 
in myocardial lipid peroxidation in CON diet animals but not 
in ANTIOX animals. Compared with ANTIOX animals, heart 
homogenates from CON animals experienced significantly 
less (P < 0.05) oxidative damage when exposed to five differ- 
ent in vitro radical producing systems. These data indicate 
that dietary supplementation with VE and a-LA protects the 
aged rat heart from I-R-induced lipid peroxidation by scav- 
enging numerous reactive oxygen species. Importantly, this 
protection is associated with improved cardiac performance 
during reperfusion. 
aging; free radicals; lipid peroxidation; myocardial perfor- 
mance 
THERE IS MUCH INTEREST in nutritional antioxidant sup- 
plementation as a therapeutic preventative strategy 
against myocardial ischemia-reperfusion (I-R) injury. 
The interest results from findings that reactive oxygen 
species (ROS) contribute significantly to myocardial 
I-R injury (11). ROS, such as superoxide anions, hy- 
droxyl radicals, and peroxyl radicals formed during 
reperfusion, can lead to lipid peroxidation within the 
cardiac myocyte, resulting in decreased cardiac perfor- 
mance (3). 
It is widely believed that an optimum antioxidant 
supplement contains more than one nutrient, and 
recently the combination of two antioxidants, vitamin 
E (VE) and a-lipoic acid (a-LA), has generated 
scientific interest. VE is the major lipid peroxidation 
chain- breaking antioxidant and is located in the 
lipid phase of the cell. When VE quenches a ROS, a 
VE radical is formed that must be recycled back to its 
reduced form to continue to provide antioxidant 
protection. Importantly, a-LA is capable of recycling 
VE (26). In addition, a-LA, reduced a-LA 
(dihydrolipoic acid), and their metabolites also 
function as antioxidants (26). a-LA has also been 
reported to be an effective glutathione substitute, 
capable of increasing cellular glutathione levels and 
further improving the antioxidant status of the 
myocardium (14). 
The combination of VE and dihydrolipoic acid 
(DHLA) has been shown to improve rodent cardiac 
performance in experiments using an in vitro I-R 
model (15, 16). In these studies, young adult animals 
were fed a high VE diet (10,000 IU/kg diet), and DHLA 
was added to the perfusion medium. The myocardial 
protection from I-R injury was reported to be due to the 
synergism of both of the two compounds (15), as op- 
posed to their individual antioxidant abilities (15). At 
present, it is unknown whether this protection is real- 
ized in vivo. 
Currently, limited information exists regarding the 
ability of antioxidant supplementation to protect se- 
nescent hearts from I-R-induced injury. This is unfor- 
tunate, given that, compared with young animals, myo- 
cardial I-R in senescent animals results in a greater 
myocardial injury (21). This observation could be 
linked to the fact that aging is associated with reduced 
myocardial antioxidant protection (32). Therefore, 
these experiments examined the effects of dietary sup- 
plementation of antioxidants (VE and a-LA) on I-R- 
induced myocardial injury in senescent animals. Spe- 
cifically, we tested the hypothesis that the dietary 
combination of VE and a-LA would provide protection 
from I-R damage in aged animals. Furthermore, on the 
basis of known antioxidant properties of VE and a-LA, 
we postulated that dietary supplements with these 
antioxidants would protect the heart against I-R lipid 
peroxidation induced by superoxide radicals, hydroxyl 
radicals, hydrogen peroxide, and peroxyl radicals. 
METHODS 
Experimental animals and dietary supplementation. Male 
Fischer-344 rats (18 mo old) were divided into two dietary 
groups: 1) a control diet (CON), n 25, and 2) a VE- and 
a-LA-supplemented diet (ANTIOX), n 26. CON animals 
were fed the AIN-93M purified diet, which contains 75 IU 
DL-a-tocopherol acetate/kg diet. ANTIOX animals were fed 
the AIN-93M purified diet with 10,000 IU DL-a-tocopherol 
acetate/kg diet and 1.65 g a-lipoic acid/kg diet. Diets were 
professionally prepared (Harlan Teklad, Madison, WI). Ani- 
mals were fed the diet for 14 wk. Randomly selected animals 
from the two dietary groups were exposed to the I-R protocol 
(CON, n 15; ANTIOX, n 14). The remaining animals 
served as sham controls by undergoing the same surgical 
interventions without I-R. These sham controls provided 
baseline data for the myocardial levels of lipid peroxidation 
and antioxidant capacity. Furthermore, ventricular tissue 
from sham controls was used for the heart homogenates that 
were subjected to the in vitro oxidative challenges. 
Experimental protocol. The in vivo I-R procedure has been 
explained in detail in previous work from our laboratory (5, 
27). Briefly, animals were anesthetized and mechanically 
ventilated, and the chest was opened by thoracotomy. Coro- 
nary occlusion was achieved by a ligature around the left 
coronary artery; occlusion was maintained for 25 min, fol- 
lowed by a 15-min period of reperfusion. During this time, 
cardiac performance was monitored by a catheter placed in 
the ascending aorta. At the completion of the experimental 
protocol, animals were euthanized with an overdose of pen- 
tobarbital sodium, and the heart was removed, washed in an 
antioxidant buffer (1 mM butylated hydroxytoluene and 100 
µM EDTA in a 50 mM sodium phosphate buffer, pH 7.4), 
and rapidly frozen for subsequent biochemical analyses. 
Assay of tissue levels of VE. Myocardial levels of VE were 
determined with HPLC by use of the protocol of Cort et al. (6). 
Tissue preparation before VE analysis consisted of mechan- 
ical homogenization in acetone (Ultra-Turrax T25, IKA 
Works, Cincinnati, OH), double extraction with petroleum 
ether, and then reconstitution in isooctane before injection 
into the HPLC (ABI Analytical Spectroflow 400). Aliquots (20 
µl) of the isooctane extract were injected onto a 250 x 4-mm, 
10-µm LiChrosorb SI column (Baird and Tatlock, Dagenham, 
UK). 
Assay of tissue levels of ex-LA. At physiological pH, the salts 
of a-LA dissociate and form lipoate. Therefore, determination 
of a-LA levels in physiological fluids or tissues is specifically 
a measure of lipoate content. Tissue levels of lipoate were 
measured according to Sen et al. (31), with slight modifica- 
tion. Frozen left ventricle samples (0.5–0.6 g) were ground to 
powder in liquid nitrogen with a mortar and pestle and then 
homogenized on ice in 2 ml of 20% metaphosphoric acid with 
a Teflon homogenizer. The homogenate was ultrasonicated 
intermittently for 100 s (10-s periods with 10 s of rest). The 
sample was extracted in hexane. After hexane evaporation 
under nitrogen, the extract was solubilized in a solvent 
containing 50% 0.2 M monochloroacetic acid, 30% acetoni- 
trile, and 20% methanol. Samples were filtered (0.22 µm) and 
frozen at -80°C for HPLC analysis. Samples (0.2 ml) were 
separated on an Alltima C18 column (250 x 4.6 mm, 5 µm; 
Alltech Associates, Deerfield, IL) by use of a mobile phase 
consisting of 50% 50 mM sodium biphosphate in water, 30% 
acetonitrile, and 20% methanol and a flow rate of 1 ml/min. 
a-LA was detected at a retention time of 9.5 min with a 
Coulechem II multielectrode electrochemical detector (model 
5100A, ESA, Chelmsford, MA). The electrodes were set at the 
following   potentials:   electrode   1,   +0.45V;   electrode   2, 
+0.85V; and guard cell: +0.90V. Data were collected using a 
PE Nelson 900 series interface [Perkin Elmer (PE), San Jose, 
CA] and processed using the PE Nelson Turbochrome 4 
(Perkin Elmer) software. Racemate mixture of lipoate, used 
as a standard, was provided by ASTA Medica (Frankfurt, 
Germany). Using this method, we obtained a linear (r2  
0.996) standard curve in the range of 0.2–0.75 nmol of li- 
poate. 
Biochemical assessment of endogenous antioxidant en- 
zymes. To determine whether our dietary treatments altered 
endogenous antioxidant enzymes, a small sample of the left 
ventricle from all animals was assayed to measure the activ- 
ities of superoxide dismutase (SOD), glutathione peroxidase 
(GPX), and catalase (CAT). SOD and GPX activities were 
determined spectrophotometrically with a modification of the 
procedures described by Oyanagui (25) and Flohé and Gü n- 
zler (8), respectively. CAT was assayed using the procedure 
described by Ji et al. (18). 
Lipid peroxidation measurements. To determine the de- 
gree of oxidative damage in the heart, left ventricular levels 
of two by-products of lipid peroxidation were measured. Ma- 
lonyldialdehyde (MDA) levels were determined spectropho- 
tometrically by use of the thiobarbituric acid-reactive sub- 
stance (TBARS) method previously described by Mihara and 
Uchiyama (24), with 1,1,3,3-tetramethoxypropane used as 
the standard. 
Lipid hydroperoxides were quantified using the ferrous 
oxidation/xylenol orange technique reported by Hermes- 
Lima (17). Cumene hydroperoxide was used as the standard 
for this assay, and values were expressed as cumene hy- 
droperoxide equivalents (CHE). 
In vitro measurement of tissue antioxidant capacity. To 
evaluate the antioxidant potential of VE and a-LA supple- 
mentation, heart homogenates from the sham surgery ani- 
mals were subjected to five different ROS-generating sys- 
tems and then analyzed for lipid peroxidation with the 
TBARS assay described above. Sections of the left ventricle 
from both ANTIOX and CON animals were homogenized at a 
concentration of 10:1 in either 0.9% (wt/vol) saline solution 
(for the aqueous generating systems) or ethanol (for the lipid 
phase system). Aliquots of the homogenates were incubated 
at a concentration of 10 mg protein/ml in the presence or 
absence of an ROS generating system. Five ROS generating 
systems were used. 1) Superoxide radicals were generated by 
a hypoxanthine-xanthine oxidase system, according to the 
method of Fridovich (9). 2) Hydrogen peroxide (100 µM) was 
added directly to heart homogenates according to the method 
of Gonzalez Flecha et al. (12). 3) Hydroxyl radicals were 
generated in the heart homogenates by adding 0.1 µM fer- 
rous sulfate (FeSO4) to heart homogenates. 4) Peroxyl radi- 
cals were generated in the aqueous phase of the homogenate 
by the addition of 9.4 mM AAPH [2,2'azobis(2-amidinopro- 
pane)-dihydrochloride] (19). 5) Peroxyl radicals were gener- 
ated in lipids in the heart homogenate by thermal decompo- 
sition of 5 mM AMVN [2,2'azobis(2–4 dimethylvaleronitrile)] 
(19). 
After incubation of the heart homogenates in each system, 
butylated hydroxytoluene (200 mM) and deferioxamine (1 
mM) in ice-cold trichloroacetic acid (20% wt/vol) were added 
to stop the oxidative reaction. TBARS formation was then 
determined, as described in Lipid peroxidation measure- 
ments. 
Statistical analysis. Biochemical data were subjected to a 
one-way ANOVA. Performance measures were analyzed us- 
ing a two-way repeated-measures ANOVA. Scheffé’s test was 
used post hoc, with significance established a priori at P < 
0.05. 
RESULTS 
Figure 1 contains the mean (±SE) myocardial VE 
and a-LA concentrations in both CON and ANTIOX 
diet animals. These data indicate that our feeding 
protocol resulted in a significant (P < 0.05) increase in 
the myocardial VE levels in the ANTIOX animals com- 
pared with CON animals. However, no significant dif- 
ferences (P > 0.05) in a-LA levels existed between the 
two groups. 
Cardiac performance was assessed during ischemia 
and reperfusion by utilizing a fluid-filled catheter 
placed in the ascending aorta to measure peak systolic 
pressure. The effects of the different diets on peak 
arterial pressure and rate-pressure product during the 
experimental protocol are shown in Fig. 2. Note that no 
significant differences existed between experimental 
groups before and during ischemia in either measure. 
However, at 2, 5, and 15 min of reperfusion, both peak 
Fig. 1. Comparison of myocardial vitamin E (A) and lipoate concen- 
trations (B) between control (CON) diet and antioxidant (ANTIOX, 
vitamin E and a-lipoic acid) diet animals. Values are means ± SE. 
*Significantly greater than CON diet (P < 0.05).
Fig. 2. Effects of CON and ANTIOX diets on peak arterial systolic 
pressure (A) and the rate-pressure product (B) during ischemia and 
reperfusion. Values are means ± SE. *ANTIOX significantly greater 
than CON (P < 0.05). 
systolic pressure and rate-pressure product were sig- 
nificantly (P < 0.05) higher in the ANTIOX animals 
compared with CON diet animals. 
Two markers of lipid peroxidation were used to de- 
termine the effects of the different diets on cardiac 
damage due to I-R. Figure 3 contains the mean (±SE) 
values for myocardial TBARS and CHE in both exper- 
imental groups. First, note that similar results were 
obtained using the two markers of lipid peroxidation. 
Also notice that, in the CON diet group, I-R surgery 
resulted in a significant increase (P < 0.05) in both 
myocardial TBARS and CHE levels compared with 
sham surgery animals. Finally, a key finding was that 
antioxidant ANTIOX I-R animals had significantly 
lower (P < 0.05) myocardial TBARS and CHE levels 
than CON I-R animals. 
Table 1 contains mean (±SE) activities of GPX, SOD, 
manganese SOD (MnSOD), copper-zinc superoxide dis- 
mutase (Cu-ZnSOD), and CAT. Several observations 
are noteworthy. First, compared with CON diet ani- 
mals, myocardial GPX activity in ANTIOX animals 
was significantly higher (P < 0.05) in both the sham 
and the I-R surgery groups. 
Second, SOD activity was greater (P < 0.05) in 
ANTIOX animals that underwent I-R surgery com- 
pared with CON diet I-R surgery animals. Further- 
more, CON diet I-R surgery animals displayed lower 
 
 
  
Fig. 3. Lipid peroxidation levels in the myocardium of rats undergo- 
ing either ischemia-reperfusion (I-R) or sham surgery and consum- 
ing either a CON or an ANTIOX diet. TBARS, thiobarbituric acid- 
reactive substance; CHE, cumene hydroperoxide equivalents. Values 
are means ± SE. *Significantly greater than sham surgery animals 
(P < 0.05); **significantly less than CON diet I-R surgery animals 
(P < 0.05). 
Fig. 4. Lipid peroxidation (TBARS assay) in heart homogenates from 
either CON or ANTIOX diet animals subjected to 4 in vitro aqueous 
phase oxidative challenges (A) and 1 lipid phase challenge (B). 
AAPH, 2,2'azobis(2-amidinopropane)-dihydrochloride; AMVN, 
2,2'azobis(2–4dimethylvaleronitrile). Values are means ± SE. *Sig- 
nificantly greater than ANTIOX diet animals exposed to the same 
treatment (P < 0.05). 
 
(P < 0.05) total SOD activity compared with CON diet 
sham surgery animals. Analysis of the different iso- 
forms of SOD indicated that these differences in total 
enzyme activity were due to changes in the manganese 
isoform of the enzyme. Finally, dietary supplementa- 
tion with VE and a-LA did not alter the myocardial 
activity of CAT in either sham surgery or I-R surgery 
groups. 
Figure 4A indicates that the myocardium from 
ANTIOX animals was significantly (P < 0.05) better 
protected against lipid peroxidation in all four aqueous 
radical-generating systems compared with the myocar- 
dium from CON diet animals. Similarly, compared 
with  CON  diet  animals,  hearts  from  antioxidant 
ANTIOX animals experienced less (P < 0.05) lipid 
peroxidation when exposed to the lipid phase (AMVN) 
oxidative challenge (Fig. 4B). 
DISCUSSION 
 
Overview of principal findings. This is the first ex- 
periment to examine the effects of VE and a-LA sup- 
plementation on cardiac performance and biochemistry 
during in vivo I-R in aged rats. A major finding of this 
study was that antioxidant supplementation improved 
cardiac performance during postischemia reperfusion. 
In addition, our data support the hypothesis that the 
dietary combination of VE and a-LA reduces myocar- 
dial lipid peroxidation resulting from an in vivo I-R 
 
Table 1. Effects of antioxidant supplementation and I-R surgery on endogenous antioxidant enzymes 
 
 
Control Diet Antioxidant-Supplemented Diet 
 
Antioxidant Enzyme 
Glutathione peroxidase, 
Sham surgery 
n = 11 
I-R surgery 
n = 15 
Sham surgery 
n = 10 
I-R surgery 
n = 14 
µmol· min-1 · mg protein-1 0.36 ± 0.02 0.43 ± 0.04 0.49 ± 0.04† 0.58 ± 0.03† 
Total superoxide dismutase, 
U/mg protein 81.6 ± 3.5 74.5 ± 3.5* 78.8 ± 3.1 80.2 ± 2.8† 
Copper-zinc superoxide dismutase, 
U/mg protein 36.9 ± 2.2 42.3 ± 4.4 36.2 ± 2.0 36.8 ± 2.9 
Manganese superoxide dismutase, 
 
U/mg protein 44.6 ± 2.9 32.2 ± 2.2* 42.6 ± 2.6 43.4 ± 2.3† 
Catalase, U/mg protein 1.50 ± 0.07 1.68 ± 0.12 1.57 ± 0.07 1.64 ± 0.06 
Values are group means ± SE; n, sample size. I-R, ischemia-reperfusion. * Different from sham surgery with same diet (P < 0.05); 
† different from control diet group with the same surgical treatment (P < 0.05). 
 
 
insult. Furthermore, in vitro experiments demon- 
strated that this dietary antioxidant combination pro- 
tected the myocardium against lipid peroxidation in- 
duced by five different radical-generating systems. 
Collectively, these data indicate that dietary supple- 
mentation with VE and a-LA protects the senescent 
heart against lipid peroxidation by scavenging a vari- 
ety of ROS and that this protection is associated with 
improved cardiac performance during reperfusion after 
myocardial ischemia. 
Antioxidant supplementation improves cardiac per- 
formance during reperfusion. An important observa- 
tion in this study was that dietary supplementation 
with VE and a-LA improved cardiac performance dur- 
ing myocardial reperfusion after ischemia. Both peak 
arterial pressure and the rate-pressure product were 
significantly higher during reperfusion in ANTIOX an- 
imals compared with CON rats. Upon reoxygenation of 
hypoxic heart tissue, cardiac performance generally 
remains depressed for several days. The cause of this 
reperfusion-induced cardiac dysfunction is believed to 
be due, at least in part, to an increased production of 
ROS during reoxygenation of the hypoxic tissue (3, 11). 
ROS have been shown to participate in numerous de- 
generative cellular processes, such as membrane lipid 
peroxidation (13). For example, damage to the sarco- 
plasmic reticulum membrane may result in dissipation 
of the important transsarcolemmal calcium gradient 
and an increase in the cytosolic calcium concentration 
(10). This could result in a sustained contractile acti- 
vation resulting in hypercontracture, distortion of the 
myocardial cytoskeleton, and diminished contractile 
performance (10). The present study suggests that this 
chain of deteriorating events might be attenuated by 
preloading the myocardium with nutritional antioxi- 
dants that decrease the ROS-induced cellular injury. 
Again, this is the first study to demonstrate in vivo 
myocardial protection from I-R injury by use of the 
combination of VE and a-LA. Our findings are in agree- 
ment with previous reports regarding the myocardial 
benefits of using a combination of VE and a-LA by use 
of an in vitro model (15, 16). In contrast, the current 
data are contradictory to recent findings from our lab- 
oratory in which young female rats were used (5). 
Using the same antioxidant regimen and I-R protocol 
as the current experiments, we observed that the an- 
tioxidant supplementation resulted in less I-R-induced 
myocardial lipid peroxidation; nonetheless, this di- 
etary intervention did not improve myocardial contrac- 
tile performance during reperfusion. At least two pos- 
sibilities can explain these discrepancies. First, 
compared with young adult animals, senescent ani- 
mals have a reduced antioxidant capacity (32). There- 
fore, it is possible that dietary antioxidant supplemen- 
tation may be more beneficial in protecting against 
ROS-mediated cardiac injury in older animals com- 
pared with young animals. 
A second possibility is that gender or strain differ- 
ences may exist in the responses of the animals to I-R. 
The previous study from our lab used female Sprague- 
Dawley rats, whereas the present study used male 
Fischer-344 rats. In this regard, it has been reported 
that enzymatic antioxidant defenses, specifically SOD 
and CAT, vary with gender and strain in rats (28). 
Furthermore, the female gonadotropic hormone estro- 
gen and its metabolites have been shown to have an- 
tioxidant capability (33). Therefore, collectively, it ap- 
pears that age, gender, and strain differences could 
have contributed to our divergent findings. 
Antioxidant supplementation reduces I-R-induced 
myocardial lipid peroxidation. Lipid peroxidation is 
one of the most damaging processes that occurs in the 
myocardium during I-R. The oxidative modification of 
lipids results in alterations to the fluidity and perme- 
ability of membrane peroxidation (13). It has been 
reported that lipid peroxidation of the sarcoplasmic 
reticulum, which occurs during I-R, may result in al- 
tered calcium handling and subsequent contractile 
dysfunction (29). In the present study, two measures of 
lipid peroxidation were used to determine whether 
dietary supplementation reduced left ventricular lipid 
damage after I-R. Compared with sham animals, I-R 
increased myocardial lipid peroxidation in CON diet 
animals. In contrast, compared with sham, I-R did not 
increase myocardial MDA and CHE in ANTIOX ani- 
mals. These findings are in agreement with studies 
that have reported decreased in vitro I-R-induced lipid 
peroxidation with prefeeding of VE alone (20) or in 
combination with a-LA (5). However, the current study 
is the first investigation to support the notion that this 
dietary antioxidant regimen reduces I-R-induced lipid 
peroxidation in the senescent heart under in vivo phys- 
iological conditions. 
In vitro oxidative challenges. To determine the mech- 
anism by which dietary supplementation with VE and 
a-LA provides protection against I-R-induced myocar- 
dial lipid peroxidation, in vitro experiments were con- 
ducted that oxidatively challenged heart homogenates 
from both CON and ANTIOX animals that were not 
exposed to I-R. Because of the antioxidant properties of 
VE and a-LA, we hypothesized that heart homogenates 
from ANTIOX animals would quench superoxide radi- 
cals, hydroxyl radicals, hydrogen peroxide, and peroxyl 
radicals generated in vitro. Our data support this pos- 
tulate. Indeed, after exposure to five ROS generating 
systems, lower levels of MDA were detected in heart 
homogenates from ANTIOX animals compared with 
CON diet animals. Therefore, the finding that the 
nutritional combination of the two antioxidants results 
in a myocardium that is protected against all five ROS 
generating systems supports the notion that combining 
aqueous and lipid phase antioxidants is therapeuti- 
cally beneficial (15). 
Effects of antioxidant supplementation and I-R on 
myocardial antioxidant enzymes. The effect of the an- 
tioxidant supplementation on activities of myocardial 
enzymes important in protection against oxidative 
stress was also investigated. Two interesting observa- 
tions warrant discussion. First, activity of GPX in- 
creased in ANTIOX animals in both the sham and I-R 
groups. This finding agrees with previous unpublished 
data from our laboratory and from other investigators 
(23, 30). The explanation for the increased GPX activ- 
ity with VE supplementation could be the increase in 
cellular selenium concentrations that accompanies VE 
supplementation (30). Selenium is a cofactor for GPX, 
and higher cellular levels of VE have been shown to 
stimulate increased expression of the enzyme. 
The second interesting finding was a significantly 
greater total SOD activity in the myocardium of 
ANTIOX animals exposed to I-R surgery compared 
with CON diet I-R surgery animals. Also, myocardial 
total SOD activity was lower in the CON diet I-R 
surgery animals compared with CON diet sham sur- 
gery animals. These differences in myocardial total 
SOD activity were due to a higher activity of the 
manganese isoform. This finding is in agreement with 
two recent studies reporting that vitamin E feeding 
upregulated MnSOD protein expression and expres- 
sion in aortic segments of rats (23) and in rats fed a 
high-fructose diet (7). The mechanisms to explain these 
findings are unknown and warrant further investiga- 
tion. 
The decreased activity of the mitochondrial isoform 
of SOD in aged animals exposed to myocardial I-R may 
be the result of an accumulation of hydrogen peroxide. 
Indeed, it has been demonstrated that hydrogen per- 
oxide is a negative allosteric modifier of MnSOD activ- 
ity (4). In the ANTIOX animals, the presence of addi- 
tional antioxidants such as a-LA, DHLA, or their 
metabolites, all of which have been shown to quench 
hydrogen peroxide, may have protected MnSOD from 
I-R-induced downregulation. 
Limitations of the model. The male Fischer-344 rat 
was chosen as the experimental subject because 1) the 
nature of these invasive experiments precludes the use 
of human subjects, 2) this strain of rat is highly inbred 
and does not display large interanimal variations in 
coronary collateral circulation, and 3) the rat is a 
widely accepted model for the study of dietary antiox- 
idant interventions and an accepted model for aging 
research (1). 
At the completion of the feeding period, our animals 
were ~21.5 mo old. The experimental rationale for 
investigating this age group of animals is as follows. 
Our objective in these experiments was to investigate 
the effects of antioxidant supplementation on I-R-in- 
duced cardiac injury in old animals that were not “old 
age survivors” (i.e., older than the median life span of 
this strain). Because the median life span of male F-
344 rats ranges from 22 to 29 mo, 21.5-mo-old ani- 
mals are approaching senescence but are not old age 
survivors. 
The decision to use 10,000 IU of VE and 1.65 g of 
a-LA per kg diet was based on previous work demon- 
strating that these dosages of VE (15, 16) and a-LA (26) 
have provided beneficial results. Also, this dietary dos- 
age of VE results in serum tocopherol levels in the rat 
of 3 mg/dl, which are similar to values obtained in 
humans when large doses (600 IU/day) of a-tocopherol 
are consumed (22). 
The surgical procedure used in these experiments 
has been used successfully in our laboratory (5, 27) and 
has been reported to result in both myocardial ische- 
mia and reperfusion (2). However, it is possible that 
this type of experimental surgery could result in in- 
teranimal differences in the magnitude of either isch- 
emia or reperfusion. Nonetheless, we believe that these 
differences are clinically relevant and better reflect the 
types of I-R insults that occur in humans. 
The decision not to include additional experimental 
groups that consumed only VE or a-LA was based on 
the data from Haramaki et al. (16). These investigators 
reported that it was the combination of the two anti- 
oxidants that provided protection and that fewer ben- 
efits were observed when they were used individually. 
Furthermore, in the current experiments, we chose not 
to include a parallel group of younger animals. This 
decision was based on previous data from our labora- 
tory indicating that dietary supplementation with VE 
and a-LA did not improve myocardial performance 
during I-R (5). Therefore, in the absence of a parallel 
group of younger animals in our current study, it is not 
possible to conclude that aging results in a compro- 
mised myocardial antioxidant capacity. 
Summary and conclusions. These experiments ex- 
amined the effects of dietary supplementation with VE 
and a-LA on myocardial physiological and biochemical 
responses during in vivo I-R in the aged rat. The 
dietary regimen yielded a significant increase in myo- 
cardial VE content after 14 wk of supplementation. 
Dietary supplementation with these antioxidants im- 
proved cardiac performance during reperfusion after 
ischemia. This improvement in recovery from ischemia 
appears to be due to the supplemented hearts being 
protected from a wide range of ROS, resulting in re- 
duced lipid peroxidation. These results indicate that 
this combination of antioxidant supplements provides 
protection against myocardial I-R injury in old ani- 
mals. 
Perspectives 
This is the first experiment to examine the effects of 
combining VE and a-LE supplementation on cardiac 
performance and biochemistry during in vivo myocar- 
dial I-R in aged rats. The results confirm previous work 
using the in vitro model to support the use of this 
antioxidant combination as a therapeutic defense 
against I-R oxidative damage. A major new finding of 
this study was that the antioxidant supplements im- 
proved cardiac performance during postischemia- 
reperfusion. In addition, our data support the hypoth- 
esis that the dietary combination of VE and a-LE 
reduces myocardial lipid peroxidation resulting from 
an in vivo I-R insult. Furthermore, we performed in 
vitro experiments indicating that this dietary antioxi- 
dant combination protected the myocardium against 
lipid peroxidation  induced by five different radical- 
generating systems. In summary, this study provides 
new and important findings relative to the therapeutic 
role of VE and a-LE in providing protection in the 
senescent heart during reperfusion after ischemia. 
This study was supported by research grants from the American 
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